| 
Citations
 | 
   web
Hira, V. V. V., Verbovsek, U., Breznik, B., Srdic, M., Novinec, M., Kakar, H., et al. (2017). Cathepsin K cleavage of SDF-1alpha inhibits its chemotactic activity towards glioblastoma stem-like cells. Biochim Biophys Acta, 1864(3), 594–603.
toggle visibility
Heffernan, J. M., McNamara, J. B., Borwege, S., Vernon, B. L., Sanai, N., Mehta, S., et al. (2017). PNIPAAm-co-Jeffamine(R) (PNJ) scaffolds as in vitro models for niche enrichment of glioblastoma stem-like cells. Biomaterials, 143, 149–158.
toggle visibility
Li, M., Xiao, A., Floyd, D., Olmez, I., Lee, J., Godlewski, J., et al. (2017). CDK4/6 inhibition is more active against the glioblastoma proneural subtype. Oncotarget, 8(33), 55319–55331.
toggle visibility
Momeny, M., Moghaddaskho, F., Gortany, N. K., Yousefi, H., Sabourinejad, Z., Zarrinrad, G., et al. (2017). Blockade of vascular endothelial growth factor receptors by tivozanib has potential anti-tumour effects on human glioblastoma cells. Sci Rep, 7, 44075.
toggle visibility
Yan, H., Romero-Lopez, M., Benitez, L. I., Di, K., Frieboes, H. B., Hughes, C. C. W., et al. (2017). 3D Mathematical Modeling of Glioblastoma Suggests That Transdifferentiated Vascular Endothelial Cells Mediate Resistance to Current Standard-of-Care Therapy. Cancer Res, 77(15), 4171–4184.
toggle visibility